CD44 and breast cancer: Further evidence supporting the intrinsic resistance of cancer stem cells to treatment was provided by a study comparing breast cancer core biopsies before and after treatment, which showed that chemotherapy leads to an increase in the proportion of cancer stem cells with the phenotype CD44+CD24−/low and to enhanced mammosphere forming efficiency (Li et al,2008).